SCHEMBL22493337

SCHEMBL22493337

CC(C)(C)NCCc1ccc(C(F)(F)F)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.45
KDM1A O60341 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
KCNH2 Q12809 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ADRB2 P07550 1/20 0.38
PDE2A O00408 1/20 0.38
POLB P06746 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MBOAT4 Q96T53 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10254379 0.85 KDM1A (0.49) DAOKDM1AMAOAMAOBKMT2A
SCHEMBL14303885 0.83 HRH3 (0.47) DAOKDM1AMAOAMAOBCTSK
SCHEMBL29721716 0.80 DAO (0.40) DAOKCNH2KDM4EMBOAT4ALDH1A1
SCHEMBL22493471 0.78 PDE10A (0.38) DAOKMT2ANPC1RAB9AKDM4E
SCHEMBL10115954 0.78 DAO (0.50) DAOKDM1AMAOAMAOBCTSS
SCHEMBL29852337 0.78 DAO (0.50) DAOKDM1AMAOAMAOBCTSS
SCHEMBL3576790 0.77 CA1 (0.47) DAOKDM1AMAOAMAOBKMT2A
SCHEMBL22864139 0.76 PDE10A (0.47) CTSLCTSBCTSSCTSKKCNH2
SCHEMBL31613889 0.75 KDM1A (0.47) DAOKDM1AMAOAMAOBKMT2A
SCHEMBL265120 0.75 LMNA (0.43) DAOKDM1AMAOAMAOBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed
WO-2023225021-A1 COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) CURASEN THERAPEUTICS, INC. (US) 2023-11-23 WO disclosed
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed